Diasome Pharmaceuticals raises at least $20M for diabetes drug trials
September 22, 2022 at 15:30 PM EDT
If the drug succeeds in clinical trials, Diasome likely would license its technology to or be acquired by a "top global pharmaceutical company," the company's commercial development leader said.